GMNYSEinactive

Optec International, Inc.

Consumer Cyclical·Oncology·Commercial·Detroit, MI, United States
OncologyPainGastroenterology

Optec International, Inc. (GM): 6 pipeline candidates · ~1 mo cash runway. Updated within the last hour.

7.5/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway0.2

0.7 months

Financial Health10.0

D/E -1.24 · 0% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth9.8

6 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Optec International, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$73.5B

Cash

$9K

Quarterly Burn

$158K

Runway

0.7 mo

Revenue

$0

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Jul 2026
Today~7 mo out
Catalyst within runway

Pipeline (6 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

1,511

Total value held

$59.64B

HolderSharesValue
vanguard capital management llc117,481,186$8.75B
blackrock, inc.82,657,510$6.16B
state street corp44,511,441$3.32B
vanguard portfolio management llc37,791,920$2.82B
franklin resources inc36,044,752$2.69B
geode capital management, llc22,024,789$1.64B
fmr llc15,108,705$1.13B
dimensional fund advisors lp14,225,518$1.06B
aqr capital management llc13,892,622$1.03B
harris associates l p13,457,709$1.00B

Showing top 10 of 1,511 institutional holders of Optec International, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·1 FDA decision·CEO: Ms. Mary T. Barra

Frequently asked questions

How many drug candidates are in Optec International, Inc.'s pipeline?

Optec International, Inc. (GM) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Optec International, Inc.'s lead drug candidate?

Optec International, Inc.'s most advanced tracked candidate is butalbital (Approved) for INDICATIONS AND USAGE Butalbital, acetaminophen and caffeine tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable..

What is Optec International, Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Optec International, Inc. has approximately 0.7 months of cash runway.

What is Optec International, Inc.'s market capitalization?

Optec International, Inc.'s market capitalization is approximately $73.5B.

Who is the CEO of Optec International, Inc.?

Ms. Mary T. Barra is the chief executive officer of Optec International, Inc. (GM).

Get the full picture on Optec International, Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.